← Back to Search

Behavioral Intervention

Educational Intervention for High Blood Sugar

N/A

Recruiting

Led By Sara Heinert, PhD, MPH

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Persons 18 years of age or older who present as patients in the Robert Wood Johnson University Hospital Emergency Department with or without a preexisting Type 2 Diabetes Mellitus diagnosis with a blood glucose of ≥200 mg/dL. Participants must speak English to participate in the study.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up initial emergency department presentation to follow-up survey (2 weeks later)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if educating patients who come to the Emergency Department with high blood sugar about Type 2 Diabetes Mellitus will increase their knowledge and lead to healthier behaviors. Participants will receive an educational

Who is the study for?

This trial is for English-speaking adults 18 or older who come to the Robert Wood Johnson University Hospital Emergency Department with high blood sugar levels (≥200 mg/dL), whether they've been diagnosed with Type 2 Diabetes Mellitus before or not.

What is being tested?

The study tests if an educational packet given during an emergency visit can boost patients' understanding of Type 2 Diabetes and encourage healthier lifestyle choices. Participants will be surveyed at their visit and two weeks later to measure the intervention's effectiveness.

What are the potential side effects?

Since this trial involves an educational intervention rather than a medical treatment, there are no direct physical side effects expected from participating in this study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ initial emergency department presentation to follow-up survey (2 weeks later)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~initial emergency department presentation to follow-up survey (2 weeks later)

This trial's timeline: 3 weeks for screening, Varies for treatment, and initial emergency department presentation to follow-up survey (2 weeks later) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Diabetes Knowledge

Secondary study objectives

Proactive and Preventative Health Behaviors

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Intervention ArmExperimental Treatment1 Intervention

Participants in the intervention arm will receive Type 2 Diabetes Mellitus educational materials that includes information regarding Type 2 Diabetes symptoms, risk factors, and resources for further follow-up care alongside standard Emergency Medicine care, which includes discharge instructions provided by ED practitioners along with verbal explanations from their assigned ED nurse.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Educational Intervention

2013

N/A

~7120

0 / 1Eligibility criteria met